What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
The DOI matches its Crossref record.
Abstract
The authors provide an overview of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study (www.star-d.org), a large-scale practical clinical trial to determine which of several treatments are the most effective "next-steps" for patients with major depressive disorder whose symptoms do not remit or who cannot tolerate an initial treatment and, if needed, ensuing treatments. Entry criteria were broadly defined and inclusive, and patients were enrolled from psychiatric and primary care clinics. All participants began on citalopram and were managed by clinic physicians, who followed an algorithm-guided acute-phase treatment through five visits over 12 weeks. At the end of each sequence, patients whose depression had not fully remitted were eligible for subsequent randomized trials in a sequence of up to three clinical trials. In general, remission rates in the study clinics were lower than expected, suggesting the need for several steps to achieve remission for most patients. There was no clear medication "winner" for patients whose depression did not remit after one or more aggressive medication trials. Both switching and augmenting appeared to be reasonable options when an initial antidepressant treatment failed, although these two strategies could not be directly compared. Further, the likelihood of remission after two vigorous medication trials substantially decreased, and remission would likely require more complicated medication regimens for which the existing evidence base is quite thin. STAR*D demonstrated that inclusion of more real-world patients in clinical trials is both feasible and informative. Policy implications of the findings, as well as the study's limitations, are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“low efficacy (only 27% of depressed patients achieved remission after 12 weeks of citalopram treatment as measured by HAM-D)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [259]
In the citing paper
“the current standard of care treatments suffer from slow onset (e.g., 7 week average response time with citalopram)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [259]
In the citing paper
“Studies examining antidepressant efficacy reveal 30% of depressed patients fail to respond to common antidepressant treatment (1)”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [1]
In the citing paper
“Currently available antidepressant medications, alone and in combination, are associated with high rates of partial- or non-response, delayed response onset of weeks to months, and limited duration of efficacy5.”
From Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants (2016) · cites this paper as [5]
In the citing paper
“while more than a third fail to achieve remission even after several rounds of treatment ( Al-Harbi, 2012 , Gaynes et al., 2009 , Strawbridge et al., 2022 )”
From Self-blame-selective hyper-connectivity between anterior temporal and subgenual cortices predicts prognosis in major depressive disorder (2023) · cites this paper as Gaynes et al., 2009
Citations
Cites
Still being checked.
Cited by
Items 501–600 of 764
Park, D., Lee, G., Kim, B. S., Seong, M., & Kim, J. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02288-9 · Cited by 4
Marques, B. L., Lirio, P. H. C., Vicente, M. A., Unzueta‐Larrinaga, P., Urigüen, L., & Campos, A. C. (2025) · Pharmaceuticals · doi:10.3390/ph18121817 · Cited by 4
Biography as the dark matter of treatment response
Horwitz, R. I., Conroy, A. H., Cullen, M. R., & Sim, I. (2026) · The American Journal of Medicine · doi:10.1016/j.amjmed.2026.01.044 · Cited by 3
Cohen, R., Bastos, J., Cunha, C., Marguilho, M., Sancho, A. V., Silva, M. J. M., King, F., & Castro-Rodrigues, P. (2026) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2026.02.001 · Cited by 3
Kaczmarek, E. S., Rodrigues, N. B., Chisamore, N., Doyle, Z., Meshkat, S., Blainey, M. G., Brudner, R. M., Ali, S., Teopiz, K. M., McIntyre, R. S., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121385 · Cited by 3
Zhukovsky, P., Kuhn, M., Borchers, L. R., Ren, B., Woronko, S. E., Li, M., Lam, C. S. T., Zhang, E. M., Ressler, K. J., Brennan, B. P., et al. (2026) · Nature Mental Health · doi:10.1038/s44220-026-00671-z · Cited by 3
Uzungil, V., Luza, S., Opazo, C., Mees, I., Li, S., Ang, C., Williamson, N. A., Bush, A. I., Hannan, A. J., & Renoir, T. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109837 · Cited by 3
Dang, Y., Lu, B., Vanderwal, T., Castellanos, F. X., & Yan, C. (2024) · Psychological Medicine · doi:10.1017/s0033291724001156 · Cited by 3
Wandel von Nutzen und Risiko antidepressiver Pharmakotherapie
Baethge, C. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01672-y · Cited by 3
Endocrinological Treatment Targets for Depressive Disorder
Yoon, S., & Kim, Y. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4402-2_1 · Cited by 3
Lee, S., Lee, Y., Mun, S., Yun, Y., Kang, H., & Lee, J. (2025) · Biomedical Chromatography · doi:10.1002/bmc.70197 · Cited by 3
Genetic and Phenotypic Associations With Sustained Antidepressant Use in Major Depressive Disorder
Walker, A., Mitchell, B. L., Lin, T., Crouse, J. J., Albiñana, C., Yap, C. X., Lynall, M.-E., Lind, P. A., Cipriani, A., Byrne, E. M., et al. (2026) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.4372 · Cited by 3
Overcoming Antidepressant Treatment Resistance: Focus on Glutamate
Murrough, J. W., & Mathew, S. J. (2010) · Modern trends in psychiatry · doi:10.1159/000319509 · Cited by 3
Conclusion: Integration and Synthesis
Choi-Kain, L. W., & Gunderson, J. G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1314-5_14 · Cited by 3
Gronemann, F. H., Lund, T., Lindholdt, L., Madsen, K. B., Jørgensen, M. B., Nordentoft, M., & Osler, M. (2022) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-022-02243-9 · Cited by 3
Sherry, T. B., Nguyen, T. D., Dick, A. W., Bradford, A. C., Simon, K. I., & Stein, B. D. (2022) · Psychiatric Services · doi:10.1176/appi.ps.20220070 · Cited by 4
Jing, P., Mei, X., Zhang, Y., Zheng, F.-J., Luo, X., Liu, L.-J., Yu, H., & Zhang, X.-B. (2023) · World Journal of Psychiatry · doi:10.5498/wjp.v13.i2.75 · Cited by 3
Goldwaser, E. L., & Aaronson, S. T. (2023) · Springer eBooks · doi:10.1007/978-3-031-15401-0_17 · Cited by 3
Depression roundtable: Is there a role for BoNT?
Kels, L. H. (2023) · Toxicon · doi:10.1016/j.toxicon.2023.107148 · Cited by 3
Epidemiology and Burden of Treatment-Resistant Depression in Colombia: Analysis of the TRAL Study
Cordoba-Rojas, R., Ferro, E., Baena, L. M. A., KANEVSKY, G. A., & Cabrera, P. (2023) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2023.04.009 · Cited by 3
Neural predictors of depression symptom course
Heller, A. S. (2015) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2014.12.023 · Cited by 3
Depressive Disorders: Major Depressive Disorder and Persistent Depressive Disorder
MacKinnon, D. F. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch50 · Cited by 3
Euba, R., Panihhidina, I., & Zamar, A. (2015) · Future Neurology · doi:10.2217/fnl.15.8 · Cited by 3
How can we make measures of psychotic depression symptoms more clinically useful?
Fava, M. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12177 · Cited by 3
Self-citationNeurophysiological mechanisms of plasticity induced in adult brain
Popova, D. (2015) · Helda - University of Helsinki Institutional Repository · Cited by 3
Measuring Adherence with Antidepressant Medication: Comparison of HEDIS and PDC Methodologies
Telinoiu, C. (2016) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/thesis-telinoiu-carmen-2016 · Cited by 3
Journey To The Centre Of The Mind: Psychedelic Treatment of Mental Health in Aotearoa
Lutyens, D. (2023) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.21904854 · Cited by 3
Mitchell, B. L., Gilroy, D., Wallace, L. M., Kiewa, J., Parker, R., Nunn, L., Walker, A., Lin, T., Ziser, L., English, G., et al. (2025) · medRxiv · doi:10.1101/2025.09.16.25335873 · Cited by 3
Peripheral immune-derived matrix metalloproteinase promotes stress susceptibility
Russo, S., Cathomas, F., Lin, H.-Y., Chan, K., Li, L., Durand-de Cuttoli, R., Parise, L., Aubry, A., Muhareb, S., Desland, F., et al. (2023) · doi:10.21203/rs.3.rs-1647827/v1 · Cited by 189
Mental Health, Substance Use, and Child Maltreatment
Ali, M. M., Lu, T. T., Maclean, J. C., & Meinhofer, A. (2024) · Journal of Health Economics · doi:10.1016/j.jhealeco.2026.103160 · Cited by 2
The neuromodulation revolution: Planning for the future of brain stimulation in psychiatry
Einstein, E. H., & Leuchter, A. F. (2024) · Transcranial magnetic stimulation . · doi:10.1016/j.transm.2024.100080 · Cited by 2
Yadav, E., Tekkalaki, B. V., Gadadavar, K. P., Yadawad, V. S., Chate, S. S., Patil, S., & Koparde, V. (2025) · Indian Journal of Psychological Medicine · doi:10.1177/02537176251334446 · Cited by 2
Levy, E., & Jung, M.-K. (2025) · Journal of Osteopathic Medicine · doi:10.1515/jom-2024-0196 · Cited by 2
Depressive symptom network patterns across age and gender
Cho, D., Kim, H., Noh, H. L., & Shim, E. (2025) · Current Psychology · doi:10.1007/s12144-025-08330-9 · Cited by 2
Xin, Q., Wei, H., Paudel, D., Hu, N.-Y., Zhao, Y., Feng, Y., Luo, X., Su, M., Xue, X., Huang, H., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-098281 · Cited by 2
Lee, S., Kim, D., Kang, H., & Lee, J. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01717-4 · Cited by 2
Njau, S. N., Zavaliangos‐Petropulu, A., Joshi, S. H., Brooks, J. O., O'Neill, J., Roger, W. P., Norris, V., Espinoza, R. T., & Narr, K. L. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70102 · Cited by 2
Xu, X., Wang, H., Cui, S., Liu, C., Song, X., & Dong, G.-H. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03837-6 · Cited by 2
Kiebach, A. M., McAlpine, T. E., Cavanaugh, M. H., & Benzer, J. A. (2024) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.2046 · Cited by 2
Kennedy, K. P., Heldt, J. P., & Oslin, D. W. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002025 · Cited by 3
Recco, K. C. C., Bonetto, G. G., Lupo, C., Nardi, A. E., Morales, A., Becerra‐Palars, C., Perocco, S., & Pfau, A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1221746 · Cited by 2
Affect, Mood, Emotions: Depressive Disorders and Bipolar and Related Disorders
Leigh, H. (2014) · Springer eBooks · doi:10.1007/978-3-319-11005-9_15 · Cited by 2
Are SSRI Antidepressants Little More than Active Placebo? A Critical Exploration.
Abi‐Jaoude, E. (2011) · Cited by 2
Greer, T. L., & Trivedi, M. H. (2014) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.12.2.146 · Cited by 2
Self-citationMind your state: Insights into antidepressant nonadherence
Wolmarans, D. W., & Brand, S. J. (2016) · South African Family Practice · doi:10.4102/safp.v58i4.4509 · Cited by 2
Narkose zur Elektrokrampftherapie
Grundmann, U., & Schneider, S. O. (2013) · Springer eBooks · doi:10.1007/978-3-642-40715-4_16 · Cited by 2
Wexler, E. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.04.016 · Cited by 2
Impact of the STAR*D Trial From the Perspective of the Payer
Little, A. A., Hansen, R. A., Gartlehner, G., & Gray, C. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1463 · Cited by 2
Han, K., Park, S., Won, E., Sung, S.-H., Lee, H., Koo, J.-W., Lee, K., Lee, H.-Y., Paik, J., Jeon, H. J., et al. (2013) · 신경정신의학 · doi:10.4306/jknpa.2013.52.5.386 · Cited by 2
Electroconvulsive therapy – a pocket guide for family doctors
Antosik-Wójcińska, A. Z., & Poleszczyk, A. (2015) · Family Medicine & Primary Care Review · doi:10.5114/fmpcr/60381 · Cited by 2
Application of Proteomic Approaches to Accelerate Drug Development for Psychiatric Disorders
Rahmoune, H., Martins‐de‐Souza, D., & Guest, P. C. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-52479-5_4 · Cited by 2
Patient Care Situations Benefiting from Pharmacogenomic Testing
Mills, R. A., Eichmeyer, J. N., Williams, L. M., Muskett, J. A., Schmidlen, T., Maloney, K. A., & Lemke, A. A. (2018) · Current Genetic Medicine Reports · doi:10.1007/s40142-018-0136-y · Cited by 2
Kaur, H., Sidana, A. K., & Singh, T. K. (2019) · Journal of Mental Health and Human Behaviour · doi:10.4103/jmhhb.jmhhb_21_19 · Cited by 3
Bahi, C. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2007.08429 · Cited by 2
Magnesium in Ketamine Administration in Treatment-Resistant Depression
Górska, N., Cubała, W. J., Słupski, J., Wiglusz, M. S., Gałuszko‐Węgielnik, M., Kawka, M., & Grzegorzewska, A. M. (2021) · Pharmaceuticals · doi:10.3390/ph14050430 · Cited by 2
Zsido, R. G., & Sacher, J. (2021) · Nomos Verlagsgesellschaft mbH & Co. KG eBooks · doi:10.5771/9783748924869-27 · Cited by 2
Holm, M., Larsen, J., Ishtiak‐Ahmed, K., Speed, M. S., Gasse, C., & Østergaard, S. D. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001505 · Cited by 2
Mo, J., Qinlong, X., Li, J., Zhaoxing, C., Ma, X., Qihua, Z., & He, G. (2023) · Letters in Drug Design & Discovery · doi:10.2174/1570180820666230418104418 · Cited by 2
Placebo effects in mental health disorders: protocol for an umbrella review
Huneke, N. T. M., Amin, J., Baldwin, D. S., Chamberlain, S. R., Correll, C. U., Garner, M. J., Hill, C. M., Hou, R. H., Howes, O. D., Sinclair, J., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073946 · Cited by 2
Prevalence of Treatment Resistant Depression: TRAL study sub analysis in a Mexican sample
Hernández, J. L. V., de la Serna, L. D. A., de la Cruz, C. D. L. C. C., Palars, C. B., Beltran, J. I., KANEVSKY, G. A., & Cabrera, P. (2023) · Archivos de Neurociencias · doi:10.31157/an.v28i4.448 · Cited by 2
Epidemiology and Burden of Treatment-Resistant Depression in Colombia: Analysis of the TRAL Study
Cordoba-Rojas, R., Ferro, E., Baena, L. M. A., KANEVSKY, G. A., & Cabrera, P. (2025) · Revista Colombiana de Psiquiatría (English ed ) · doi:10.1016/j.rcpeng.2025.10.007 · Cited by 2
Managing major depressive disorder through the use of adjunct therapies
Katzman, M. A. (2014) · Psychiatry Research · doi:10.1016/s0165-1781(14)70001-0 · Cited by 2
Rosenblat, J. D., Lee, Y. L., Mansur, R. B., Brietzke, E. M., & McIntyre, R. S. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.10.017 · Cited by 2
Wade, B., Pindale, R., Camprodon, J. A., Luccarelli, J., Li, S., Meisner, R. C., Seiner, S. J., & Henry, M. (2023) · Research Square · doi:10.21203/rs.3.rs-3682009/v1 · Cited by 2
Krauss, J. K., & Nagel, J. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00212-6 · Cited by 2
O Renascimento da Medicina Psicodélica
Kuligowski, R. C. M., Schroeder, E. M., Pelizzari, J. V., Fortunato, M., & Cavalli, R. O. (2022) · E-Acadêmica · doi:10.52076/eacad-v3i3.298 · Cited by 1
Time to get it right: investing in the mental wellbeing of people living with HIV
Pence, B. W., & Gaynes, B. N. (2023) · AIDS · doi:10.1097/qad.0000000000003554 · Cited by 1
Self-citationKerr‐Gaffney, J., Zenasni, Z., Goldsmith, K., Yaziji, N., Jin, H., Colasanti, A., Geddes, J. R., Kessler, D. S., McAllister-Williams, H., Young, A. H., et al. (2025) · Health Technology Assessment · doi:10.3310/yqvf5347 · Cited by 1
Analysis of interval censored survival data in sequential multiple assignment randomized trials
Li, Z. (2025) · Lifetime Data Analysis · doi:10.1007/s10985-025-09665-y · Cited by 1
Novozhenova, A. N., Dolotov, O. V., & Grivennikov, I. A. (2025) · Molecular Genetics Microbiology and Virology (Russian) · doi:10.17116/molgen202543042111 · Cited by 1
Xu, J.-Y., Li, C.-C., Zhang, H.-C., Guo, L.-J., Geng, M.-Y., He, X., Wang, L.-Y., Li, H., Wang, Y.-J., Xu, Q., et al. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01708-2 · Cited by 1
Haghparast, P., Olotu, B., & Yuan, C. (2026) · Mental Health Clinician · doi:10.9740/mhc.2026.02.030 · Cited by 1
Kato, M., Baba, T., Nakano, S., Kashiwagi, Y., Motomiya, T., & Iwata, N. (2026) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70320 · Cited by 1
CXCL12/CXCR4 axis as a modulator of neurotransmission in depression: A neuroimmune perspective
Grzybowska, K., Czarny, P. L., Kolodziej, L. R., Wigner, P., Szemraj, J., Gałecki, P., Su, K., & Śliwiński, T. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106717 · Cited by 1
The Revolution in Rapid-Acting Antidepressants
Sanacora, G., & Duman, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.04.020 · Cited by 1
Gene expression in major depressive disorder: Peripheral tissue and brain-based studies
Mignogna, K. M., & Goes, F. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817933-8.00095-5 · Cited by 1
Tailoring antidepressant therapy based on genetic profiles
Shammari, Y. H. A., Shammari, H. A. A., Barak, T. M. B., Alharbi, B. S., Alshammari, S. T., Alnais, S. A., Aljohani, S. A., Alorf, A. A., Alnawmasi, M. A., Alshammari, M. A., et al. (2018) · International Journal of Health Sciences · doi:10.53730/ijhs.v2ns1.14915 · Cited by 1
Psychiatric Nosology: Approaches to the Characterization of Mental Disorders
Nestadt, P. S., Seymour, K. E., Potash, J. B., & McHugh, P. R. (2019) · Oxford University Press eBooks · doi:10.1093/oso/9780190916602.003.0003 · Cited by 1
Mindfulness-based cognitive therapy and depression
Ewais, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817933-8.00042-6 · Cited by 1
Risk of Medication Exposures in Pregnancy and Lactation
Brooks, E., Cox, E., Kimmel, M., Meltzer-Brody, S. E., & Ruminjo, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-71497-0_6 · Cited by 1
Hierarchical MAP Denoising of Longitudinal Hamilton Depression Rating Scores
Koss, J., DeLorenzo, C., & Tagare, H. D. (2021) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm52615.2021.9669362 · Cited by 1
P.044 Effects of exercise and environmental enrichment in serotonin transporter knock-out mice
Rogers, J., Chen, F., Stanić, D., Farzana, F., Li, S., Zeleznikow-Johnston, A., Nithianantharajah, J., Churilov, L. P., Adlard, P. A., Lanfumey, L., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.109 · Cited by 1
Lupo, C., Bonetto, G. G., Corral, R. M., Vilapriño, M., Alessandria, H., KANEVSKY, G. A., & Perocco, S. (2023) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i161.484 · Cited by 1
Zambrano, J., Hernández, J. L. V., Rigal, F. F. B., de la Serna, L. D. A., KANEVSKY, G. A., & Perocco, S. (2023) · Archivos de Neurociencias · doi:10.31157/an.v1iinpress.634 · Cited by 1
Utilizing Pharmacogenomics Results to Guide Antidepressant Selection: A Case Report
Vernacchia, N. P., Toro-Pagán, N. M. D., Bardolia, C., & Amin, N. S. (2024) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2024.143 · Cited by 1
Modulation of gut microbiota in the therapy of mental disorders – new therapeutic strategies
Bystron, J. M., & Dziekiewicz, A. (2024) · Environmental Medicine · doi:10.26444/ms/187949 · Cited by 1
de Filippis, R., & Foysal, A. A. (2024) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2024.157025 · Cited by 1
The role of psilocybin in depressive disorders
Najib, J. S. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2396536 · Cited by 1
Nowak, K., Wingralek, Z. J., Banaszek, A., & Próchnicki, M. (2024) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2024.0019 · Cited by 1
Hooshyar, D., & Bruton, M. (2024) · Medical Care · doi:10.1097/mlr.0000000000002049 · Cited by 1
Tundo, A., Betrò, S., de Filippis, R., Felici, R., Lucangeli, C., & Iommi, M. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001986 · Cited by 1
Algorithm for the biological treatment of acute episode of recurrent depressive disorder
Mosolov, S. N., Костюкова, Е. Г., & Ladyzhensky, M. (2016) · Современная терапия психических расстройств · doi:10.21265/psyph.2016.38.3561 · Cited by 1
Antidepressant-Antianxiety Agents
Baldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_4 · Cited by 1
Umemoto, A. (2016) · UVic’s Research and Learning Repository (University of Victoria) · Cited by 1
Choi, E. (2015) · QSpace (Queen's University Library) · Cited by 1
Temperament and Character in Depression, Anxiety, and Alcohol Use Problems
Paavonen, V. (2020) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Identifying the mechanisms of antidepressant drug action in mice lacking brain serotonin
Petermann, M. (2021) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/23035 · Cited by 1
Rasmijn, A. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220315ar · Cited by 1
Timäus, C., Vogelgsang, J. S., Kis, B., Radenbach, K., Wolff‐Menzler, C., Mavridou, K., Gyßer, S., Heßmann, P., & Wiltfang, J. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01275-7 · Cited by 1
Subbaiah, M. A. M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01619 · Cited by 1
Metadata
- Authors
- Gaynes, B. N., Warden, D., Trivedi, M. H., Wisniewski, S. R., Fava, M., & Rush, A. J.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- The University of Texas Southwestern Medical Center (US)
- University of Pittsburgh (US)
- National University of Singapore (SG)
- Venue
- Psychiatric Services
- Published
- 2009-11
- Volume
- 60
- Issue
- 11
- Pages
- 1439-1445
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2095852687
- Cited by
- 661
- References
- 0
- Citations by year
- 2026: 37 · 2025: 47 · 2024: 57 · 2023: 73 · 2022: 61 · 2021: 58 · 2020: 55 · 2019: 48 · 2018: 41 · 2017: 42 · 2016: 28 · 2015: 33 · 2014: 20 · 2013: 20 · 2012: 16
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychiatric Services (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- University of Texas Southwestern Medical Center
- National Institutes of Health (n01mh90003-26-0-0)
- National Institute of Mental Health (N01‐MH‐90003)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- STAR*D, major depressive disorder, antidepressant treatment, treatment-resistant depression, remission, citalopram, antidepressant switching, antidepressant augmentation, primary care, psychiatric clinic
- MeSH terms
- Venlafaxine Hydrochloride, Adolescent, Adult, Aged, Cyclohexanols, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Primidone, Remission Induction, Time Factors, Citalopram, Cognitive Behavioral Therapy, Bupropion, Treatment Outcome, Treatment Failure, Selective Serotonin Reuptake Inhibitors, Dopamine Uptake Inhibitors, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.